Bayer Plc v NHS Darlington CCG and Others
Back of an eye showing age-related macular degeneration Author US National Eye Institute Source Wikipedia Jane Lambert Administrative Court (Mrs Justice Whipple) Bayer Plc v NHS Darlington CCG and other s [2018] EWHC 2465 (Admin) 21 Sept 2018 This case was an application by Bayer Plc and Novartis Pharmaceuticals UK Ltd . for judicial review of a decision by 12 clinical commissioning groups ( "CCGs" ) in Northeast England to offer patients with wet AMD ( age-r elated macular degeneration) injections of a drug known as Avastin or bevacizumab. The reason for their decision is that Avastin costs £28 per injection compared to £816 for Bayer's EYLEA and £551 for Novartis's Lucentis . The CCGs had made their decision to save money. The only problem was that Avastin had been developed for the treatment of cancer and not ophthalmology whereas the other two drugs had been authorized...